The genotypes and susceptibilities to fluconazole of 78 strains of the huma
n pathogenic yeast Candida albicans were compared. The strains comprised tw
o sets of samples from Durham, N.C.: one from patients infected with the hu
man immunodeficiency virus (HIV) and the other from healthy volunteers. For
each strain, the MIC of fluconazole was determined by the standard Nationa
l Committee for Clinical Laboratory Standards protocol. Genotypes were dete
rmined by PCR fingerprinting,vith five separate primers. The analysis revea
led little evidence for genotypic clustering according to HN status or body
site. However, a small group of fluconazole-resistant strains isolated fro
m patients infected with HIV formed a distinct cluster. In addition, two fl
uconazole-resistant strains were isolated from individuals who never took f
luconazole, one from a patient infected with HIV and the other from a healt
hy person. The results suggest both clonal and spontaneous origins of fluco
nazole resistance in C. albicans.